Waters has donated a state-of-the-art ACQUITY TQD system, a liquid chromatograph/mass spectrometer to the University at Buffalo?s school of pharmacy.
Waters has donated a state-of-the-art ACQUITY TQD system, a liquid chromatograph/mass spectrometer to the University at Buffalo’s school of pharmacy.
The instrument will be used to train graduate students, post-doctoral and clinical fellows and advance research into the treatment of HIV and AIDS-related illnesses in sub-Saharan Africa.
It will be used as part of an ongoing effort between the University at Buffalo (UB)/University of Zimbabwe (UZ) AIDS International Training and Research Programme (UB/AZ AITRP), a joint programme managed by the UB and UZ and funded in part by the National Institutes of Health (NIH) and the Fogarty International Centre.
Dr Gene D. Morse, associate director of UB’s New York state centre of excellence in bioinformatics and life sciences and professor at the school of pharmacy and pharmaceutical sciences, said, “Our mission has been to establish a bridge between the University at Buffalo and Zimbabwe to train clinician scientists on a state-of-the-art instrumentation and grow the capacity for clinical and translational research that will impact medical care in Zimbabwe. That’s why Waters donation is so important. It¹s a tremendous boost to the programme and we’re very thankful.”
Dr Mark Bruns, senior director of Waters clinical business operations, commented, “Waters is honoured to make a second donation of our value-added research tools to such an important international health programme. Waters is committed to making its leading technologies accessible to researchers who can translate its power of discovery, and a deeper understanding of disease and disease management, into far-reaching impact around the globe.”
For more information please visit ref="http://www.waters.com">www.waters.com
Targeted Blood Lipidomics of Colorectal Cancer: An HTC-18 Interview with Jef Focant
July 26th 2024At HTC-18 in Leuven, Executive Editor of LCGC International, Alasdair Matheson, spoke to Jef Focant from the University of Liege about his talk entitled, “Targeted Blood Lipidomics of Colorectal Cancer."
Carol Robinson Awarded 2024 Lifetime Achievement European Inventor Award
July 24th 2024Carol Robinson of the University of Oxford has received the European Inventor Award 2024 for Lifetime Achievement from the European Patent Office for her work bringing mass spectrometry to structural biology.